Skip to main content
Premium Trial:

Request an Annual Quote

TIGR, Virginia Tech Sign Broad Collaboration Agreement

NEW YORK, Nov. 8 (GenomeWeb News) - The Institute for Genomic Research and Virginia Tech have signed a broad collaboration agreement, the institutions said today.


TIGR wants to build both on existing collaborations with the Virginia Bioinformatics Institute at Virginia Tech, as well as work with other groups at Virginia Tech that are involved in translational biology and high-end computing. TIGR and VBI each operate a recently funded national BioinformaticsResourceCenterto study pathogens and also plan to expand collaborations between these.


"There are clearly many areas of mutual interest and complementary capabilities at Virginia Tech and TIGR," TIGR President Claire Fraser said in a statement today. The partners plan to conduct joint research, share related facilities, appoint adjunct faculty, and involve students in research. The focus of research projects will be in microbial, plant, and animal genomics as well as functional genomics.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.